Stock listing

Csl Limited

Selected listing: 890952 · LS · EUR · DE

Csl Limited (Lang & Schwarz: 890952), Health Technology. Latest release Oct 5, 2026: CSL and Alentis announce global partnership to develop and commercialise…

890952:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: 890952
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Csl Limited

The company is known for its focus on biotechnology and biopharmaceuticals, providing innovative products and services in the healthcare sector. As a key player in its industry, Csl Limited continues to contribute to advancements in medical treatments and therapies.

Latest news from Csl Limited

CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases

October 4, 2026

CSL enters exclusive agreement with Alentis Therapeutics

October 4, 2026

CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign

September 29, 2026

Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks

September 22, 2026

Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults

September 10, 2026

All Csl Limited news →

Events

Replays

CSL Limited (CMXHF) Q4 2026 Earnings Call
Tue, Aug 18, 2026 · 08:00 PM ET
Watch
CSL Limited (CMXHF) Q2 2026 Earnings Call
Tue, Feb 10, 2026 · 06:00 PM ET
Watch
CSL Limited (CMXHF) Q4 2025 Earnings Call
Mon, Aug 18, 2025 · 08:00 PM ET
Watch

Research Csl Limited

Csl Limited company profile

View the public company page for Csl Limited on 6ix.

Csl Limited news

Read company news and market updates connected to Csl Limited.

Csl Limited investor events

Find investor webinars, events, and replay context for Csl Limited.